{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:18:53Z","timestamp":1788286733996,"version":"build-2803163510"},"reference-count":28,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Hanyang University Research Fund","award":["HY-202300000003499"],"award-info":[{"award-number":["HY-202300000003499"]}]},{"name":"Hanyang University Research Fund","award":["HY-202000000003333"],"award-info":[{"award-number":["HY-202000000003333"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Extraintestinal manifestations (EIMs) significantly contribute to morbidity in individuals with inflammatory bowel disease (IBD); however, population-based East Asian data remain limited. We evaluated EIM burden in a nationwide Korean IBD cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This nationwide retrospective cohort study was conducted using data from the Korean National Health Insurance Service between 2005 and 2017. Individuals with ulcerative colitis (UC) or Crohn\u2019s disease (CD) were identified using the International Classification of Diseases\u201310th Edition and rare intractable disease codes. EIM incidence, associated risk factors, interval from IBD diagnosis to EIM onset, and trends by sex and age were examined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Among 69\u2009414 individuals with IBD (48\u2009689 UC, 20\u2009725 CD), 42.23% developed at least 1 EIM. Dermatologic manifestations were the most common (17.02%), followed by musculoskeletal (16.36%), hepatopancreaticobiliary (15.48%), and ophthalmologic (7.83%) manifestations. Low socioeconomic status, smoking history, female sex, and higher Charlson Comorbidity Index scores independently correlated with EIM development in UC (hazard ratios of 2.14, 1.18, 1.15, and 1.08, respectively) and CD (hazard ratios of 1.98, 1.20, 1.18, and 1.09, respectively). Most EIMs developed within 4 to 6\u2009years postdiagnosis, with musculoskeletal EIMs occurring earliest (median 42.9\u2009months [interquartile range: 10.3-89.5 months]). Annual EIM incidence increased steadily over time across all age groups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>EIMs affected 42.23% of Korean individuals with IBD, most frequently appearing 4 to 6\u2009years postdiagnosis. Low socioeconomic status, smoking history, female sex, and higher Charlson Comorbidity Index scores consistently correlated with EIM occurrence, and incidence increased steadily over time, highlighting the need for sustained, personalized monitoring and timely intervention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ibd\/izag068","type":"journal-article","created":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:54:16Z","timestamp":1775044456000},"page":"1760-1769","source":"Crossref","is-referenced-by-count":0,"title":["Extraintestinal manifestations in Korean patients with inflammatory bowel disease: A nationwide population-based study from 2005 to 2017"],"prefix":"10.1093","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-3526","authenticated-orcid":false,"given":"Sung Sil","family":"Park","sequence":"first","affiliation":[{"name":"Department of Surgery, Hanyang University Hospital , Seoul,","place":["Korea"]},{"name":"Department of Surgery, College of Medicine, Hanyang University , Seoul,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun Jin","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pre-Medicine, College of Medicine, Hanyang University , Seoul,","place":["Korea"]},{"name":"Biostatistics Lab, Medical Research Collaborating Center, Hanyang University , Seoul,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3212-8223","authenticated-orcid":false,"given":"Byung Kyu","family":"Ahn","sequence":"additional","affiliation":[{"name":"Department of Surgery, Hanyang University Hospital , Seoul,","place":["Korea"]},{"name":"Department of Surgery, College of Medicine, Hanyang University , Seoul,","place":["Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"2026090114013353000_izag068-B1","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/S0140-6736(07)60751-X","article-title":"Inflammatory bowel disease: clinical aspects and established and evolving therapies","volume":"369","author":"Baumgart","year":"2007","journal-title":"Lancet"},{"key":"2026090114013353000_izag068-B2","doi-asserted-by":"publisher","first-page":"S253","DOI":"10.1016\/S1590-8658(08)60534-4","article-title":"Extraintestinal manifestations of inflammatory bowel disease","volume":"40 Suppl 2","author":"Ardizzone","year":"2008","journal-title":"Dig Liver Dis."},{"key":"2026090114013353000_izag068-B3","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"2026090114013353000_izag068-B4","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1053\/j.gastro.2016.10.020","article-title":"Understanding and preventing the global increase of inflammatory bowel disease","volume":"152","author":"Kaplan","year":"2017","journal-title":"Gastroenterology"},{"key":"2026090114013353000_izag068-B5","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2017","journal-title":"Lancet"},{"key":"2026090114013353000_izag068-B6","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.dld.2020.06.046","article-title":"Extraintestinal manifestation of inflammatory bowel disease in Asian patients: a multinational study","volume":"53","author":"Park","year":"2021","journal-title":"Dig Liver Dis"},{"key":"2026090114013353000_izag068-B7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1136\/gut.42.3.387","article-title":"Peripheral arthropathies in inflammatory bowel disease: their articular distribution and natural history","volume":"42","author":"Orchard","year":"1998","journal-title":"Gut"},{"key":"2026090114013353000_izag068-B8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1159\/000504701","article-title":"Gender differences in inflammatory bowel disease","volume":"101 Suppl 1","author":"Greuter","year":"2020","journal-title":"Digestion"},{"key":"2026090114013353000_izag068-B9","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.4065\/81.11.1462","article-title":"Smoking and inflammatory bowel disease: a meta-analysis","volume":"81","author":"Mahid","year":"2006","journal-title":"Mayo Clin Proc"},{"key":"2026090114013353000_izag068-B10","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study","volume":"9","author":"Lakatos","year":"2003","journal-title":"World J Gastroenterol"},{"key":"2026090114013353000_izag068-B11","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1007\/s10620-025-08868-5","article-title":"Prevalence, clinical features, and extraintestinal manifestations in patients with familial inflammatory bowel diseases","volume":"70","author":"Liava","year":"2025","journal-title":"Dig Dis Sci"},{"key":"2026090114013353000_izag068-B12","doi-asserted-by":"publisher","first-page":"e0200363","DOI":"10.1371\/journal.pone.0200363","article-title":"Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients","volume":"13","author":"Yang","year":"2018","journal-title":"PLoS One"},{"key":"2026090114013353000_izag068-B13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ecco-jcc\/jjad108","article-title":"ECCO guidelines on extraintestinal manifestations in inflammatory bowel disease","volume":"18","author":"Gordon","year":"2024","journal-title":"J Crohns Colitis"},{"key":"2026090114013353000_izag068-B14","doi-asserted-by":"publisher","first-page":"5984","DOI":"10.3390\/jcm10245984","article-title":"Temporal relationship of extraintestinal manifestations in inflammatory bowel disease","volume":"10","author":"Fedor","year":"2021","journal-title":"J Clin Med"},{"key":"2026090114013353000_izag068-B15","doi-asserted-by":"publisher","first-page":"1794","DOI":"10.1097\/MIB.0000000000000429","article-title":"Chronological order of appearance of extraintestinal manifestations relative to the time of IBD diagnosis in the Swiss inflammatory bowel disease cohort","volume":"21","author":"Vavricka","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"2026090114013353000_izag068-B16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1037\/\/0003-066x.49.1.15","article-title":"Socioeconomic status and health: the challenge of the gradient","volume":"49","author":"Adler","year":"1994","journal-title":"Am Psychol"},{"key":"2026090114013353000_izag068-B17","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1038\/s41380-018-0259-2","article-title":"Socioeconomic status and inflammation: a meta-analysis","volume":"25","author":"Muscatell","year":"2020","journal-title":"Mol Psychiatry"},{"key":"2026090114013353000_izag068-B18","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1097\/01.meg.0000243883.47938.aa","article-title":"Relationship between clinical features of Crohn\u2019s disease and the risk of developing extraintestinal manifestations","volume":"19","author":"Barreiro-de Acosta","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"2026090114013353000_izag068-B19","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","article-title":"Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease","volume":"10","author":"Karmiris","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2026090114013353000_izag068-B20","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1093\/ibd\/izy004","article-title":"Sex-related differences in patients with inflammatory bowel disease: results of 2 prospective cohort studies","volume":"24","author":"Severs","year":"2018","journal-title":"Inflamm Bowel Dis"},{"key":"2026090114013353000_izag068-B21","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1111\/j.1572-0241.2001.03755.x","article-title":"Gender-related differences in the clinical course of Crohn\u2019s disease","volume":"96","author":"Wagtmans","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"2026090114013353000_izag068-B22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.cellimm.2015.01.018","article-title":"Estrogen receptors regulate innate immune cells and signaling pathways","volume":"294","author":"Kovats","year":"2015","journal-title":"Cell Immunol"},{"key":"2026090114013353000_izag068-B23","doi-asserted-by":"publisher","first-page":"6255","DOI":"10.3390\/ijerph20136255","article-title":"Depressive and anxiety disorders in patients with inflammatory bowel diseases: are there any gender differences?","volume":"20","author":"Fracas","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"2026090114013353000_izag068-B24","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41586-023-06968-8","article-title":"Smoking changes adaptive immunity with persistent effects","volume":"626","author":"Saint-Andr\u00e9","year":"2024","journal-title":"Nature"},{"key":"2026090114013353000_izag068-B25","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1093\/ecco-jcc\/jjv190","article-title":"Impact of new treatments on hospitalisation, surgery, infection, and mortality in IBD: a focus paper by the epidemiology committee of ECCO","volume":"10","author":"Annese","year":"2016","journal-title":"J Crohns Colitis"},{"key":"2026090114013353000_izag068-B26","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.3390\/biomedicines12081839","article-title":"Extraintestinal manifestations in Inflammatory Bowel Disease: from pathophysiology to treatment","volume":"12","author":"Faggiani","year":"2024","journal-title":"Biomedicines"},{"key":"2026090114013353000_izag068-B27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/gut.2006.103564","article-title":"Risks and benefits of biologic therapy for inflammatory bowel diseases","volume":"56","author":"D\u2019Haens","year":"2007","journal-title":"Gut"},{"key":"2026090114013353000_izag068-B28","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1136\/annrheumdis-2013-204627","article-title":"The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study","volume":"73","author":"Cross","year":"2014","journal-title":"Ann Rheum Dis"}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/9\/1760\/68197352\/izag068.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article-pdf\/32\/9\/1760\/68197352\/izag068.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T18:01:46Z","timestamp":1788285706000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/32\/9\/1760\/8665955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":28,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,4,30]]},"published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izag068","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9]]},"published":{"date-parts":[[2026,4,30]]}}}